Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (428)
2023 (585)
2022 (723)
2021 (1399)
2020 (842)
All (3977)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Intensive Care Med
JSON
ISSN
1432-1238
ISSN-L
0342-4642
IUID
2c95a919b4104580b7bf6c878ce42826
Modified
2020-11-27T13:14:50.664Z
Created
2020-11-27T11:47:55.424Z
Year 2023
PubMed
DOI
Crossref
Echocardiography phenotypes of right ventricular involvement in COVID-19 ARDS patients and ICU mortality: post-hoc (exploratory) analysis of repeated data from the ECHO-COVID study.
Huang S, Vieillard-Baron A,
Evrard B
, ...,
Vignon P
, ECHO-COVID study group
Intensive Care Med
49
(8) 946-956 [2023-08-00; online 2023-07-12]
Category: Health
Type: Journal article
PubMed
DOI
Crossref
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies.
Grasselli G
, Calfee CS, Camporota L, ..., Cecconi M, European Society of Intensive Care Medicine Taskforce on ARDS
Intensive Care Med
49
(7) 727-759 [2023-07-00; online 2023-06-16]
Category: Health
Type: Other
Year 2022
PubMed
DOI
Crossref
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study.
Greco M
,
De Corte T
,
Ercole A
, ...,
Cecconi M
, ESICM UNITE-COVID investigators
Intensive Care Med
48
(6) 690-705 [2022-06-00; online 2022-05-21]
Category: Health
Type: Journal article
PubMed
DOI
Crossref
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.
Granholm A, Kjær MN, Munch MW, ..., Lange T,
Perner A
Intensive Care Med
-
(-) - [2022-03-31; online 2022-03-31]
Category: Health
Type: Journal article
Year 2021
PubMed
DOI
Crossref
Randomised clinical trials in critical care: past, present and future.
Granholm A
, Alhazzani W, Derde LPG, ..., Perner A, Møller MH
Intensive Care Med
-
(-) - [2021-12-02; online 2021-12-02]
Type: Review
PubMed
DOI
Crossref
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial.
Granholm A
, Munch MW, Myatra SN, ..., Lange T, Perner A
Intensive Care Med
-
(-) - [2021-11-10; online 2021-11-10]
Category: Drug Discovery
Category: Health
Type: Journal article
Year 2020
PubMed
DOI
Crossref
Correction to: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.
Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, ..., Villar J, COVID-19 Spanish ICU Network
Intensive Care Med
-
(-) - [2020-12-02; online 2020-12-02]
Type: Other
PubMed
DOI
Crossref
How to ventilate obese patients in the ICU.
De Jong A, Wrigge H, Hedenstierna G, ..., Pickkers P, Jaber S
Intensive Care Med
46
(12) 2423-2435 [2020-10-23; online 2020-10-23]
Type: Review
PubMed
DOI
Crossref
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
Jerath A, Ferguson ND, Cuthbertson B
Intensive Care Med
46
(8) 1563-1566 [2020-08-00; online 2020-06-25]
Type: Review
SciLifeLab Data Centre
Publications
9.5.1